Controversies in the medical management of breast cancer.
D000277:Adjuvants, Pharmaceutic / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008593:Menopause; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D013629:Tamoxifen / Q000627:therapeutic use
D000277:Adjuvants, Pharmaceutic; D006728:Hormones; D013629:Tamoxifen